Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A

Xianjun Fang, Shuang Yu, Yiling Lu, Robert C. Bast, James R. Woodgett, Gordon B. Mills

Proceedings of the National Academy of Sciences · 2000 · 838 citations · 34 references

Concepts

TL;DR

Glycogen synthase kinase 3 (GSK‑3) regulates metabolism, gene expression, cell fate, proliferation, and survival, and its activity is inhibited by phosphorylation at serine 21 (α) and serine 9 (β), residues previously identified as targets of the PI3K‑dependent protein kinase B (PKB/Akt). The study investigates whether serine 21 and serine 9 of GSK‑3α and GSK‑3β are also physiological substrates of cAMP‑dependent protein kinase A (PKA). Biochemical experiments demonstrate that PKA physically associates with, phosphorylates, and inactivates both GSK‑3 isoforms. Thus, GSK‑3 activity can be modulated either by growth‑factor–driven PI3K–PKB signaling or by hormone‑stimulated GPCR pathways that elevate intracellular cAMP.

Abstract

Glycogen synthase kinase 3 (GSK-3) is implicated in multiple biological processes including metabolism, gene expression, cell fate determination, proliferation, and survival. GSK-3 activity is inhibited through phosphorylation of serine 21 in GSK-3α and serine 9 in GSK-3β. These serine residues of GSK-3 have been previously identified as targets of protein kinase B (PKB/Akt), a serine/threonine kinase located downstream of phosphatidylinositol 3-kinase. Here, we show that serine 21 in GSK-3α and serine 9 in GSK-3β are also physiological substrates of cAMP-dependent protein kinase A. Protein kinase A physically associates with, phosphorylates, and inactivates both isoforms of GSK-3. The results indicate that depending on the stimulatory context, the activity of GSK-3 can be modulated either by growth factors that work through the phosphatidylinositol 3-kinase–protein kinase B cascade or by hormonal stimulation of G protein-coupled receptors that link to changes in intracellular cAMP levels.

References

34